摘要号：OP0026

The Efficacy and Safety of Telitacicept Following Rituximab Immunotherapy on Antiphospholipid Syndrome, A Prospective 24 weeks Study

利妥昔单抗免疫疗法后泰它西普对抗磷脂综合征的疗效和安全性：一项为期24周的前瞻性研究

讲者：Qiang Shu

单位：山东大学齐鲁医院

摘要号：OP0037

A multicenter, randomized, placebo-controlled, double-blind, phase 3 study of SHR0302, a selective danus kinase 1 inhibitor, in patients with active rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs

一项SHR0302治疗类风湿关节炎急性发作期患者以及对传统合成改善病情抗风湿药物反应不佳者的多中心、随机、安慰剂对照、双盲、3 期研究

讲者：Jinjing Liu

单位：北京协和医院

摘要号：OP0045

Analysis of Ovarian Dysfunction and related serological indicators in SSc

SSc患者卵巢功能障碍及相关血清学指标分析

讲者：Liyi Dai

单位：北京大学第三医院

摘要号：OP0050

Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease

评估超氧化物歧化酶在抗MDA5阳性皮肌炎相关间质性肺病中的价值

讲者：Lin Tang

单位：重庆医科大学附属第二医院

摘要号：OP0079

A Randomized, Double-Blind, Placebo-and-Tocilizumab Controlled Phase II Trial of VDJ-001, A High-Affinity IL-6R Antagonist Antibody, for the Treatment of Patients with Rheumatoid Arthritis

高亲和性IL-6R拮抗剂抗体VDJ-001治疗类风湿关节炎患者的随机、双盲、安慰剂/托珠单抗对照II期试验

讲者：Hua Ye

单位：北京大学人民医院

摘要号：OP0083

Malignancy risk stratification and detection rate in a Hong Kong Myositis Cohort using the International Myositis Assessment and Clinical Studies Group Guideline on Cancer Screening

根据国际肌炎评估和临床研究小组癌症筛查指南对香港肌炎患者队列进行恶性肿瘤风险分层和检出率分析

讲者：Iris Yan Ki Tang

单位：香港大学医学系风湿病及临床免疫学系

摘要号：OP0115

Identification and Validation of Anti-Protein Arginine Methyltransferase 5 (PRMT5) Antibody as a Novel Propelling Antibody for Systemic Sclerosis (SSc)

对系统性硬化症 (SSc) 新型抗体——抗蛋白精氨酸甲基转移酶 5 (PRMT5) 抗体的鉴定和验证

讲者：Minrui Liang

单位：复旦大学附属华山医院

摘要号：OP0121

Immune Cell Signatures of Patients with Different Subtypes of Behcet's Disease

不同亚型白塞病患者的免疫细胞特征

讲者：Huijie Yuan

单位：华中科技大学附属深圳医院

摘要号：OP0129

A 12-week, multicenter, randomized, double-blind, placebo-controlled, phase 2 study of ruzinurad (SHR4640) in combination with febuxostat for primary gout and hyperuricemia with an inadequate response to febuxostat alone

Ruzinurad (SHR4640) 联合非布司他治疗单用非布司他效果不佳的痛风及高尿酸血症者：一项为期 12 周、多中心、随机、双盲、安慰剂对照的2期研究

讲者：Huihua Ding

单位：上海交通大学医学院附属仁济医院

摘要号：OP0144

Multiple Spatial Proteomics to define Endothelial Cell Phenotypes and alterations of the Vascular Niche in SSc

采用多空间蛋白质组学定义 SSc 的内皮细胞表型和血管生态改变

讲者：Minrui Liang

单位：复旦大学附属华山医院

摘要号：OP0154

TLR2 increasing CD8+T cell cytotoxicity by activating mitophagy in primary Sjogren's syndrome

TLR2 通过激活原发性干燥综合征的线粒体自噬来增加 CD8+T 细胞的细胞毒作用

讲者：Zhou Zhou

单位：中国科学技术大学附属第一医院

摘要号：OP0157

CCL2-CCR2 axis mediates decidual monocyte/macrophage infiltration and inflammation in obstetric antiphospholipid syndrom

CCL2-CCR2轴在产科抗磷脂综合征中介导蜕膜单核细胞/巨噬细胞浸润和炎症

讲者：Rui Gao

单位：四川大学华西第二医院

摘要号：OP0171

Single-cell Immune Landscape of Affected Lungs from the patients with anti- MDA5-positive Dermatomyositis

抗 MDA5 阳性皮肌炎伴肺部受累患者的单细胞免疫谱

讲者：Xiaoming Zhang

单位：中国科学院上海巴斯德研究所